參考文獻/References:
[1] LUO Z,YANG F,HONG S,et al.Role of microRNA alternation in the pathogenesis of gouty arthritis[J].Front in Endocrinol,2022,13:967769.
[2] TAO H,MO Y,LIU W,et al.A review on gout:looking back and looking ahead[J].Int Immunopharmacol,2023,117:109977.
[3] 朱坤智,盧濤,羅張風,等.四肢痛風石外科治療時機和適應證[J].中國組織工程研究,2021,25(30):4883-4889.
[4] 陳兆軍,梁歡,馬玉峰,等.痛點超聲電導透射清熱利濕方藥治療急性痛風性關節(jié)炎濕熱瘀結(jié)證[J].中醫(yī)正骨,2021,33(12):48-50.
[5] CAO J F,YANG X Y,XIONG L,et al.Exploring the mechanism of action of dapansutrile in the treatment of gouty arthritis based on molecular docking and molecular dynamics[J].Front Physiol,2022,13:1828.
[6] YANAI H,ADACHI H, HAKOSHIMA M,et al.Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome,cardiovascular diseases and chronic kidney disease[J].Int J Mol Sci,2021,22(17):9221.
[7] 中國中西醫(yī)結(jié)合學會風濕類疾病專業(yè)委員會.痛風及高尿酸血癥中西醫(yī)結(jié)合診療指南[J].中醫(yī)雜志,2023,64(1):98-106.
[8] 賈萍,陳剛,楊娟,等.四妙丸對大鼠痛風性關節(jié)炎發(fā)展的影響及調(diào)控巨噬細胞極化研究[J].中華中醫(yī)藥雜志,2022,37(6):3498-3502.
[9] DONG L,ZHANG S,CHEN L,et al.In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from[J].Biomed Pharmacother,2023,161:114532.
[10] 謝強,周思平,黃冰林.旴江流域及旴江醫(yī)學地域分布今考[J].江西中醫(yī)學院學報,2012,24(6):11-14.
[11] 周步高,何曉暉,潘源樂,等.試論旴江醫(yī)學對中醫(yī)學發(fā)展的貢獻和價值[J].中華中醫(yī)藥雜志,2022,37(3):1254-1257.
[12] 謝強,章德林,黃冰林.旴江醫(yī)派志略(續(xù)三)[J].江西中醫(yī)藥,2019,50(11):3-7.
[13] 李欽才,章德林.江醫(yī)學《壽世保元》治療痛風經(jīng)驗探析[J].江西中醫(yī)藥,2021,52(6):5-7.
[14] 丁兆輝,萬麗玲.以三因制宜觀淺探江西地區(qū)濕熱咳嗽易感性[J].江西中醫(yī)藥,2014,45(3):10-11.
[15] 朱震亨.格致余論[M].北京:人民衛(wèi)生出版社,2005:15.
[16] 張亞楠,謝晨,李建民.李建民教授治療慢性腎臟病合并高尿酸血癥的臨證經(jīng)驗[J].中國中西醫(yī)結(jié)合腎病雜志,2020,21(8):666-669.
[17] 李君霞,王茂杰,黃閏月,等.痛風中醫(yī)證型的研究進展[J].中華中醫(yī)藥學刊,2018,36(12):2956-2958.
[18] 章曉云,曾浩,李華南,等.痛風性關節(jié)炎的發(fā)病機制及中醫(yī)藥治療研究進展[J].中國實驗方劑學雜志,2022,28(11):256-267.
[19] 張涵雨,李艷.國醫(yī)大師李濟仁治療痹病用藥規(guī)律分析[J].中醫(yī)學報,2020,35(1):99-104.
[20] 王麗華,曾文泓,梅鷗,等.楊鳳云教授辨治急性痛風性關節(jié)炎經(jīng)驗[J].醫(yī)學信息,2020,33(22):161-162.
[21] 李華南,賈蒙,彭偉雄,等.鄧運明教授固中清消法治療痛風學術思想研究[J].時珍國醫(yī)國藥,2019,30(6):1493-1495.
[22] 李華南.鄧運明教授學術思想傳承研究及其治療痛風性關節(jié)炎經(jīng)驗總結(jié)[D].南京:南京中醫(yī)藥大學,2015.
相似文獻/References:
[1]鄧偉哲,王宏晶,王宇恒,等.微創(chuàng)針刀鏡治療難治性膝關節(jié)類風濕關節(jié)炎[J].中醫(yī)正骨,2015,27(11):42.
[2]李藝彬,朱勇,吳昭克.關節(jié)鏡下多入路全關節(jié)滑膜清理術治療肘關節(jié)類風濕關節(jié)炎[J].中醫(yī)正骨,2015,27(11):56.
[3]胡鋼鋒,肖魯偉,童培建.關節(jié)液代謝組學在類風濕關節(jié)炎診斷
及寒熱證候分型中的應用[J].中醫(yī)正骨,2015,27(01):5.
HU Gangfeng,XIAO Luwei,TONG Peijian.Application of joint fluid metabolomics to diagnosis and COLD-HEAT SYMPTOM COMPLEX typing in patients with rheumatoid arthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):5.
[4]熊輝,曲良燁,向黎黎,等.痛風性關節(jié)炎濕熱證病證結(jié)合模型的建立[J].中醫(yī)正骨,2014,26(03):14.
Xiong Hui*,Qu Liangye,Xiang Lili,et al.A rat model of gouty arthritis combined with dampness-heat syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):14.
[5]孫克民,王平,盧啟貴,等.關節(jié)鏡下滑膜切除術聯(lián)合中藥口服
治療早期膝關節(jié)類風濕關節(jié)炎[J].中醫(yī)正骨,2013,25(09):39.
[6]李峰,郭艷幸,曹向陽,等.貫葉連翹灌胃聯(lián)合光動力療法對類風濕關節(jié)炎白兔膝關節(jié)滑膜組織病理形態(tài)的影響[J].中醫(yī)正骨,2014,26(09):6.
Li Feng*,Guo Yanxing,Cao Xiangyang,et al.Effect of intragastric administration of hypericum perforatum combined with photodynamic therapy on the pathological morphology of synovial tissue of knee joints in rabbits with rheumatoid arthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):6.
[7]嚴超,劉喜德,張金祿,等.蜂針療法治療膝骨性關節(jié)炎的護理[J].中醫(yī)正骨,2013,25(01):74.
[8]王笑青,張永紅,侯宏理,等.頑痹清丸聯(lián)合非甾體抗炎藥及改善病情的抗風濕藥治療濕熱痹阻型類風濕關節(jié)炎[J].中醫(yī)正骨,2013,25(03):41.
WANG Xiao-qing*,ZHANG Yong-hong,HOU Hong-li,et al.Curative effect and safety of WANBIQING pills combined with nonsteroidal antiinflammatory drugs and disease modifying antirheumatic drugs in the treatment of rheumatoid arthritis of dampness-heat stagnation type[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(05):41.
[9]黃建武,黃建華,林愛麗.扶中清痹通絡湯聯(lián)合益賽普對活動期類風濕關節(jié)炎患者腫瘤壞死因子-α及血管內(nèi)皮生長因子血清含量的影響[J].中醫(yī)正骨,2013,25(05):9.
HUANG Jian-wu*,HUANG Jian-hua,LIN Ai-li.*.Effect of FUZHONG QINGBI TONGLUO decoction combined with etanercept on the serum contents of tumor necrosis factor-alpha and vascular endothelial growth factor in patients with active rheumatoid arthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(05):9.
[10]赫軍,李麗華,王相奇,等.痛風四妙湯加味治療痛風性關節(jié)炎[J].中醫(yī)正骨,2013,25(05):56.
[11]齊新宇,向黎黎,熊輝,等.基于高蛋白飲食建立雞痛風性關節(jié)炎模型的量效關系研究[J].中醫(yī)正骨,2015,27(02):1.
QI Xinyu,XIANG Lili,XIONG Hui,et al.A dose-effect relationship study of gouty arthritis chicken model built by high-protein diet[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):1.
[12]齊新宇,熊輝,周彪,等.蠲痹歷節(jié)清方干預雞急性痛風性關節(jié)炎模型的
實驗研究[J].中醫(yī)正骨,2015,27(03):5.
QI Xinyu,XIONG Hui,ZHOU Biao,et al.Juanbilijieqing Fang(蠲痹歷節(jié)清方)interfere with acute gouty arthritis chiken model[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):5.
[13]陳鵬,郭文韜,龍美兵,等.退癀消腫湯聯(lián)合洛索洛芬鈉片治療急性痛風性關節(jié)炎的臨床研究[J].中醫(yī)正骨,2016,28(08):19.
CHEN Peng,GUO Wentao,LONG Meibing,et al.Clinical study on Tuihuang Xiaozhong Tang(退癀消腫湯)combined with loxoprofen sodium tablets for treatment of acute gouty arthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):19.
[14]孫瑞,郭愛菊,杜梅紅,等.能譜CT尿酸基(鈣 圖像在慢性痛風性關節(jié)炎診斷中的應用價值[J].中醫(yī)正骨,2017,29(03):30.
[15]閔星星,王鵬鵬,劉佳歡,等.第1跖趾關節(jié)痛風性關節(jié)炎的手術治療進展[J].中醫(yī)正骨,2018,30(01):47.
[16]郭玉星,熊輝,周彪,等.Nod樣受體家族含pyrin結(jié)構(gòu)域蛋白3
和嘌呤能離子通道型受體7在急性痛風性
關節(jié)炎發(fā)病中的作用研究進展[J].中醫(yī)正骨,2018,30(08):39.
[17]蔣恩宇,孫波.中藥外敷法治療急性痛風性關節(jié)炎的研究進展[J].中醫(yī)正骨,2019,31(04):56.
[18]徐艷玲,杜獻麗,杜敏,等.痛風性關節(jié)炎的延續(xù)護理[J].中醫(yī)正骨,2020,32(05):74.
[19]陳兆軍,梁歡,馬玉峰,等.痛點超聲電導透射清熱利濕方藥治療急性痛風性關節(jié)炎濕熱瘀結(jié)證[J].中醫(yī)正骨,2021,33(12):48.
[20]顧富城,楊美鑫,林惠紅,等.基于Toll樣受體/髓系分化初級反應蛋白質(zhì)88信號通路探討四妙湯加土茯苓方治療急性痛風性關節(jié)炎的作用機制[J].中醫(yī)正骨,2024,36(08):9.
GU Fucheng,YANG Meixin,LIN Huihong,et al.The mechanism of Simiaotang and Tufuling Fang(四妙湯加土茯苓方)for treatment of acute gouty arthritis:a Toll-like receptor/myeloid differentiation primary response protein 88 signaling pathway-based experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(05):9.